Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes
Rybelsus from Novo Nordisk is officially the first oral GLP-1 drug approved for this indication. The FDA's decision was based on the SOUL trial, which included data from more than 9,000 patients with type 2 diabetes.
PET holds promise for carotid plaque assessments
PET has already gained significant momentum in recent years. Now, researchers are pointing to another possible use for the popular imaging modality: assessing carotid artery atherosclerosis.
New-onset AFib is common after CABG—but typically not persistent or symptomatic
The study's authors questioned if these patients should even be given oral anticoagulation as currently recommended.
Hospital in Mexico earns first heart failure certification of its kind
A facility outside the United States has received the American Heart Association's Comprehensive Heart Failure Center Certification for the first time.
Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM
No medications are currently approved for the treatment of nonobstructive hypertrophic cardiomyopathy. Could a new drug from Imbria Pharmaceuticals be the first?

Incomplete neurovascular imaging work-ups to blame for subsequent stroke in patients with TIA

Up to 37% of patients presenting with transient ischemic attack do not receive a full neurovascular imaging work-up, according to new data published in the American Journal of Roentgenology.

Cardiologist ordered to pay $2.6M after foreign material left in patient’s femoral artery

The patient's leg remains disfigured years after the incident.

EnCompass Technologies F2 embolic filter device TAVR embolic device

Interventional cardiologists perform world’s first TAVR with new embolic protection device

The device, designed with improved filtration and stability in mind, is now being investigated as part of a new pilot study.

TAVR controversy: Surgeon fired after saying cardiologist treated patients without proper credentials

An Ohio doctor allegedly performed multiple procedures without the proper credentials. A vascular surgeon is now out of work for sharing the story with a local media outlet.

How CT creates barrier to treating pulmonary embolism patients in cheaper outpatient settings

Rather than being discharged, low-risk PE patients often receive unnecessary additional services and overnight stays, experts wrote in JAMA.

Ultrasound AI could help standardize trauma care

Trauma patients who present with poor blood flow and suspected abdominal hemorrhage are well served by emergency physicians using AI-augmented FAST imaging.

Sam Jones, MD, explains why CMS reduced payments for EP ablation and how it will negatively impact electrophysiology. #HRS #HRS2023 #EPeeps #EPlab #Medicare

Making sense of the huge Medicare reimbursement cuts in electrophysiology

Samuel Jones, MD, examines the large reimbursement reductions in cardiac ablations and what the impact might be on access to care in EP labs.

FDA approves sotagliflozin, the new heart failure drug from Lexicon Pharmaceuticals

The drug, which should be available by the end of June, will be marketed under the name Inpefa.

Clinical

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes

PET holds promise for carotid plaque assessments

New-onset AFib is common after CABG—but typically not persistent or symptomatic

Hospital in Mexico earns first heart failure certification of its kind

Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM